Initial Assessment of SARS-CoV-2 Omicron Variant in Exhaled Breath Aerosol

Authors:
  • JGJennifer German
    Jennifer German
  • BABarbara Albert
    Barbara Albert
  • ASAditya K Sirkakulapu
    Aditya K Sirkakulapu
  • MSMaria Schanz
    Maria Schanz
  • MOMolly Oertel
    Molly Oertel
  • NFNaja Fadul
    Naja Fadul

Abstract
From December 16 through 21 of 2021, we collected exhaled breath aerosol (EBA) from five members of a University campus community infected with SARS-CoV-2 viruses displaying an S-gene target failure when assayed using the TaqPath COVID-19 Real Time PCR Assay (Thermo Scientific).